Navigation Links
New UT Arlington research could improve pharmaceuticals testing
Date:4/30/2014

A UT Arlington chemistry professor, renowned for his work in the area of chemical separations, is leading an effort to find a more accurate way to measure water content in pharmaceuticals a major quality issue for drug manufacturers.

Daniel W. Armstrong, UT Arlington's Robert A. Welch Chair in Chemistry, says the new technique could be 100 times more sensitive than one of the most popular current methods.

"The analysis for water in many consumer products, including drugs, is one of the most required tests done in the world," said Armstrong. "Current methods have many shortcomings, including poor sensitivity and reproducibility; they cannot be used for all products and they can be time consuming. I believe our new 'ionic liquid' method offers improvements in all these areas."

Armstrong and two graduate students recently wrote about their new research in a paper that will be in the June issue of the Journal of Pharmaceutical and Biomedical Analysis. The publication describes using headspace gas chromatography and an ionic liquid gas chromatography column Armstrong's lab developed to measure moisture content in active pharmaceutical ingredients such as ibuprofen, tetracycline and ephedrine. Water content can affect the stability and shelf life of a drug and, when it is too high, cause microbial growth, according to the paper.

Chromatography is the process of separating a chemical mixture to measure its components. Headspace gas chromatography, or HSGC, involves the measuring of volatile analytes, or chemical components, as they diffuse into a "headspace" at the top of a tube of sample, including solids. The new method combines HSGC with the use of ionic liquids. Ionic liquids consist of a mixture of positively and negatively charged molecules. They have a variety of advantages as solvents.

Currently, two methods are most commonly used to measure moisture content. One is called weight loss on drying, or LOD; the other is called Karl Fischer Titration, or KFT. The newly described work from Armstrong's lab is useful on more types of drug ingredients than LOD and is more than 100 times more sensitive in some cases than KFT. It also can be used for much smaller samples and be automated, the paper said.

Graduate student Lillian A. Frink is lead author on the paper and Choyce A. Weatherly, also a graduate student in Armstong's lab, is a co-author.

"We think industry will utilize this method based on its broad applicability, its high accuracy, and the sample size requirements," said Frink. "It also doesn't have side-reactions like current methods, which make them inaccurate."

Armstrong has been a leader in the characterizing and synthesizing ionic liquids. He also holds patents on several open tubular capillary gas chromatography columns that utilize ionic liquids, including those used in the current research.

The newly published paper is called "Water determination in active pharmaceutical ingredients using ionic liquid headspace gas chromatography and two different detection protocols." It is available here: http://www.ncbi.nlm.nih.gov/pubmed/24561336.


'/>"/>

Contact: Traci Peterson
tpeterso@uta.edu
817-521-5494
University of Texas at Arlington
Source:Eurekalert

Related medicine news :

1. National Academy of Inventors names 4 UT Arlington professors as fellows
2. George Strait Tickets Dallas Arlington TX at the AT&T Stadium: Cheap Concert Tickets Reports Record Demand for King George's Final Concert in Dallas - Tickets Onsale 12/6
3. George Strait Tickets Dallas TX - AT&T Stadium: Ticket Down Reports Demand is through The Roof for George Strait Tickets in Arlington at AT&T Stadium (Cowboys Stadium)
4. UT Arlington professor will use NSF funds to reveal reactions inner workings
5. Dentist in Arlington, VA, Dr. Michael Rogers Launches New Website
6. Rich Dad Education to Hold 3-Day Financial Workshop in Arlington, VA on Aug. 23-25
7. UT Arlington researcher finds that money motivates employees to lose weight
8. Minimally Invasive SpineCARE® Opens Three New Clinics in Texas Branches out into Burleson, Arlington and Joshua
9. 7th Annual Reglera Reproductive Compliance Conference Slated for September 19-20, in Arlington, Virginia
10. Residence Inn Arlington Pentagon City Hotel Shows Strength With Unveiling of New Fitness Center
11. RE/MAX Suburban Brokers in Arlington Heights Plan June 8 Garage Sale to Benefit Lurie Children’s Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based ... In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... company had 800 customers and 2,250 RCEs at the time of acquisition. In ...
(Date:2/27/2017)... , ... February 27, 2017 , ... New Jersey ranks ... among all types and genders. And the need for advanced services is growing. ... its top-rated cancer care program, in collaboration with their non-profit partners in their fight ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... NuevaCare, a ... as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important ... Bay Area consumers look for home care close to home, and by having city-specific ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ODH, Inc.™ ... Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director ... to use behavioral health analytics to improve Medicaid population health management. , ODH will ...
(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology: